Susquehanna International Group, LLP Uro Gen Pharma Ltd. Put Options Transaction History

Susquehanna International Group, LLP

  • $568 Billion
  • Q1 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 07, 2024
BUY
$13.81 - $19.33 $371,489 - $519,976
26,900 New
26,900 $403,000
Q3 2023

Nov 14, 2023
BUY
$8.84 - $22.64 $45,968 - $117,728
5,200 Added 39.1%
18,500 $259,000
Q2 2023

Aug 11, 2023
BUY
$8.75 - $14.29 $116,375 - $190,057
13,300 New
13,300 $137,000

Others Institutions Holding URGN

# of Institutions
113
Shares Held
24M
Call Options Held
46.9K
Put Options Held
44.3K
View Full List

About UroGen Pharma Ltd.

URGN Quotes by TradingView
  • Ticker URGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 22,740,500
  • Market Cap $361M
  • Description
  • UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...
More about URGN
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email